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Abstract
We performed association analysis under a previous linkage peak on chromosome 16 with
genome-wide single-nucleotide polymorphism (SNP) data to identify genetic variants underlying
body mass index (BMI). Data from all subjects with baseline measures and a subgroup who had
complete data at four selected time points from the Framingham Heart Study were analyzed. The
cross-sectional measures include BMI at baseline for all subjects, as well as BMI at selected time
points for the subgroup. The longitudinal measure is the within-subject mean of BMI for the
s u b g r o u pa tt h ef o u rt i m ep o i n t s .
Association analysis was first performed using PLINK after dividing large pedigrees into nuclear
f a m i l i e s .W et h e nf o l l o w e du pt h ei d e n t i f i e dregions by variance-components methods as
implemented in SOLAR using the extended pedigrees.
The strongest evidence for associations were observed at 52.3 Mbp (PLINK p = 0.00002, QTLD
p = 0.005), on the FTO gene, and at 48.1 Mbp (PLINK p = 0.002, QTLD p = 0.0006) on
chromosome 16, which are directly under the previous identified linkage peak. This association was
consistently observed for all samples at baseline, and for the subgroup at time point 2, 3, 4 and
M E A N ,b o t hb yP L I N Ka n dS O L A R .I na d d i t i o n ,a n o t h e rS N P / r e g i o na t4 6 . 7M b po ns a m e
chromosome was found to be associated with several BMI measures in the subgroup. Fine-mapping
with more markers provided further evidence for SNP association with BMI in the same region (at
52.4 Mbp, QTLD p = 0.0003).
These results suggest the existence of genes/DNA variations in these regions that contribute to
BMI variation.
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Obesity, which is influenced by both genetic and
environmental factors, is an independent risk factor for
coronary heart disease (CHD). However, the reported
quantitative trait loci (QTLs) for body mass index (BMI)
are not consistent. The discrepancy among various
studies represents the difficulty in identifying suscept-
ibility genes for common complex traits. Many factors,
including, but not limited to sample size, ascertainment
method, long-term or short-term environmental influ-
ences, and genetic heterogeneity, all may contribute to
the discrepancy among studies. Age-dependent pene-
trance of a trait is another factor that may complicate the
identification of susceptibility genes.
Cross-sectional study designs collecting phenotypic data
at one time point are used in most genetic studies,
mainly due to their relative feasibility. However, long-
itudinal data may answer questions that cross-sectional
data cannot. A longitudinal study with measures at
multiple time points might be the best solution for gene
mapping studies of traits with age-dependent pene-
trance. Furthermore, serial observations over time of the
same trait may allow more accurate partitioning of
genetic and environmental components than would a
single observation [1]. Thus, longitudinal data may
provide more and/or different insight in dissecting the
genetics of a complex trait.
The Framingham Heart Study (FHS) is a successful
longitudinal study of cardiovascular diseases. Started in
1948, FHS has obtained longitudinal cardiovascular-
related phenotypic measures in two generations of
participants. A 10-cM genome-wide scan in subjects
from 330 families was carried out in the late 1990s and
several suggestive linkage regions were identified for
BMI [2]. The highest linkage peak was observed on
chromosome 16 and it was consistent for each time
point. Lately, 500 k single-nucleotide polymorphisms
(SNPs) across the genome and 50 k SNPs in follow-up
candidate genes were genotyped. This provided a
unique opportunity to map QTLs for CHD-related
traits.
Our goals in this study were: 1) to identify QTLs for BMI
using an association approach, taking into account the
linkage information we had obtained in the previous
genome-wide linkage studies [2]; and 2) to assess the
consistency of QTLs identified over time using the FHS
data. Follow-up association tests for SNPs within the
previously identified linkage regions and evaluation of
association with multiple time point measures should
increase the power to identify the true positives. In order
to improve the power of identifying true-positive
association (i.e., considering linkage information), and
avoid a huge number of multiple tests, we focused our
association study on chromosome 16.
Methods
Subjects
Three cohorts were recruited in the FHS. Both the
Original Cohort (Generation 1) and Offspring Cohort
(Generation 2) had data collected at baseline and three
follow-up visits. The Generation 3 had only baseline
measures. Using the cross-sectional measures from
baseline, a total of 960 extended pedigrees consisting
of 6475 subjects were used in the genome-wide associa-
tion analysis of BMI.
In order to evaluate the longitudinal effect and to make
association analysis results from different time points
comparable, we also analyzed those subjects with
phenotypic data at all the four selected visits as a
subgroup (Original and Offspring Cohorts only). Only
families with at least two blood-related individuals who
met such criteria were included in the analysis.
Phenotype
BMI [weight (kg)/height (m)
2] was selected as the
quantitative trait because of its completeness and
uniform method of measurement over time. Baseline
BMI was denoted as BMI-B. For the subgroup of the
Original and Offspring Cohorts, five measures of BMI,
denoted as BMI1, BMI2, BMI3 and BMI4 (Visit 1, 4, 7, 11
for the Original Cohort; Visit 1, 3, 5, 7 for the Offspring
Cohort) as well as MEAN (the within-subject mean of
the four visits over years), were analyzed.
Statistical analysis
Data quality control (QC) was performed using PLINK
to remove SNPs with minor-allele frequency (MAF) less
than 0.05 and to zero out mendelian inconsistencies [3].
SNPs with higher missing rate (>0.1) or failing the
Hardy-Weinberg test at 0.01 significance level were also
excluded from analysis. Samples with lower genotyping
rates (<0.9) were removed. Approximately two-thirds of
SNPs passed QC and were used in the association
analysis. In addition, Relcheck was also performed to
identify errors in the familial relationships [4]. Proble-
matic individuals were excluded for further analysis.
Because of the limitations of the analysis program and
time constraints, the association between each SNP and
BMI was first evaluated using nuclear families (by
dividing the large pedigrees) and the program PLINK
[3] with 100,000 permutations. PLINK assesses associa-
tion by the linear model and adjusts for family
relatedness by permutation. Because the total number
of SNPs on chromosome 16 was around 10,800, we set
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and being located under the identified linkage peaks.
Follow-up association analysis for the selected region
and fine-mapping were conducted using extended
families by the variance-components analysis method
as implemented in the SOLAR program [5,6]. Three
methods were utilized for association test by SOLAR:
measured genotype analysis, quantitative trait transmis-
sion disequilibrium test (QTDT) and quantitative trait
linkage disequilibrium (QTLD). The orthogonal model
w a su s e di nt h eQ T D Tm e t h o d ,i nw h i c ht h et o t a l
association is partitioned into orthogonal within- and
between-family components. The between-family com-
ponent was sensitive to population stratification, while
the within-family structure was free of confounding by
family structure effect and was significant only in the
presence of linkage disequilibrium. QTLD was a mod-
ification of QTDT, which considered the founders’
information when population stratification is absent [6].
Association test for quantitative traits was performed on
BMI-B, BMI1-BMI4, and the MEAN under the additive
model. Age, sex, and cohort were included as covariates
in the association analyses.
Results
Association for baseline BMI (BMI-B) using genome-wide
association study (GWAS) data on chromosomes 16
Using divided nuclear families (n = 6475 subjects),
5 SNPs (52.3 Mbp) met the selection criteria, i.e.,
p < 0.0001 and located under the previous identified
linkage region (highest LOD = 3.0 at 45 cM) [2] on
chromosome 16. Several other SNPs had p = 0.001 and
were within 10 cM of the peak (45-55 Mbp) (Figure 1).
Applying SOLAR to extended families, the top SNP was
found to be rs11647781 at 48.1 Mbp (PLINK p = 0.002,
QTLD p = 0.0006), while the SNPs identified by PLINK at
5 2 . 3M b pr e m a i n e ds i g n i f i c a nt. The top SNP in the latter
region was rs9926289 (PLINK p = 0.00002, QTLD
p = 0.005, Table 1). In general, p-values were consistent
from the three different methods (measured genotype
analysis, QTDT, and QTLD) and so we only reported the
p-value from QTLD in Table 1.
Association for four time points (BMI1, BMI2, BMI3 and
BMI4) and MEAN BMI for the subgroup using GWAs data
Although using a subgroup of samples (n = 2702) may
reduce the power to identify the association, we observed
SNP associations similar to BMI-B for BMI2, BMI3,
BMI4, and MEAN (Table 1). Interestingly, an additional
SNP (rs16945869, 46.7 Mbp) was identified to be
associated with all five BMI measures in this subgroup.
Fine-mapping on selected regions
Within the same region, we selected 150 additional SNPs
from the fine-mapping markers to further test the
associations for all subjects and the subgroup samples.
Only one fine-mapping SNP in the same region
(rs2042032, 52.4 Mbp) showed significant association
(QTLD p = 0.0004) for baseline BMI for all subjects.
Another fine-mapping SNP (rs16945874, 47.6 Mbp),
which is in the same region as the SNP identified in the
subgroup samples (rs16845869), also remained signifi-
cant (QTLD p =2×1 0
-6 for BMI1 and MEAN) in this
subgroup.
Discussion
We performed association analyses on chromosome 16
using genome-wide scan SNP data for BMI measured at
different time points and the mean of BMI over a
number of years on the FHS sample. The strongest
evidence for association was observed at 52.3 Mbp and
48.1 Mbp, which are directly under the previously
identified linkage peak. The most consistent associations
were observed in baseline BMI for all samples and most
time points and MEAN for the subgroup by different
analysis methods. The p- v a l u e st e n d e dt ob es m a l l e rf o r
all samples, possibly due to the relatively larger sample
size. Fine-mapping with more markers confirmed the
associations in the same region. Two additional SNPs at
46.7 Mbp (one from the original GWAS and the other
from fine-mapping) were identified in the subgroup
only.
One of the major issues for GWAS is separating true and
false positives due to the huge number of multiple tests.
Combining the information from previous linkage
studies may provide additional power to identify true
associations. On chromosome 16, the second most
significant p-value and several tentative associations
was observed under the previous identified linkage
region, and the evidence for association were consis-
tently observed by different statistical analysis methods
as well as for different samples. Considered these
together, we believe that there must be some genes or
DNA variants in this region that contribute to the
determination of BMI. The most significant region we
identified (52.3 Mbp) harbors FTO,ag e n ew h i c hw a s
f o u n dt ob ea s s o c i a t e dw i t hf a tm a s sa n do b e s i t y .R e c e n t
studies have reported that the variants of this gene are
associated with body fat distribution and a variety of
metabolic traits, such as insulin resistance, diabetes, and
high-density lipoprotein cholesterol level [7].
Using longitudinal observations of BMI, we derived
MEAN as a longitudinal phenotype that represents an
overall status of BMI over years. Although the sample
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Association test of BMI-B, BMI1, BMI2, BMI3, BMI4, and MEAN on chromosome 16 by PLINK.a ,B M I - B ;b ,B M I 1 ;
c, BMI2; d, BMI3; e, BMI4; f, MEAN. Black line with dots: 10-cM range of linkage peak.
Table 1: p-Value for associated SNPs under the linkage peak (p < 0.0001 by PLINK or p < 0.001 by QTLD for one or more BMI
measures)
SNP Position
(bp)
BMI-B BMI1 BMI2 BMI3 BMI4 MEAN
PLINK QTLD PLINK QTLD PLINK QTLD PLINK QTLD PLINK QTLD PLINK QTLD
rs16945869
a 46732060 0.219 0.026 0.004 7.8 × 10
-6 0.006 0.0002 0.039 0.0006 0.001 10
-5 0.002 4.6 × 10
-6
rs11647781 48151920 0.002 0.0006 0.024 0.04 0.023 0.020 0.030 0.31 0.005 0.021 0.011 0.024
rs4785326 48173088 0.014 0.001 0.06 0.07 0.15 0.034 0.074 0.22 0.041 0.09 0.048 0.05
rs9939973 52358069 0.00014 0.010 0.019 0.18 0.002 0.06 0.001 0.016 0.00061 0.028 0.00044 0.012
rs9940128 52358255 0.00006 0.008 0.022 0.22 0.003 0.08 0.002 0.023 0.00051 0.028 0.00048 0.017
rs1121980 52366748 0.00016 0.011 0.023 0.22 0.002 0.09 0.002 0.025 0.00037 0.027 0.00035 0.017
rs7193144 52368187 0.00008 0.006 0.019 0.12 0.003 0.07 0.003 0.007 0.001 0.011 0.00074 0.006
rs8050136 52373776 0.00006 0.007 0.023 0.15 0.004 0.10 0.003 0.008 0.001 0.009 0.00069 0.007
rs9926289 52378004 0.00002 0.005 0.020 0.25 0.003 0.25 0.004 0.030 0.00086 0.023 0.00077 0.029
rs9939609 52378028 0.00002 0.008 0.018 0.15 0.003 0.12 0.002 0.010 0.001 0.013 0.00049 0.008
aBold font indicates the most significant SNPs.
BMC Proceedings 2009, 3(Suppl 7):S101 http://www.biomedcentral.com/1753-6561/3/S7/S101
P a g e4o f5
(page number not for citation purposes)size was much smaller (2702 vs. 6475), we identified
similar SNPs as those found in the analysis of all samples
at baseline only. In general, BMI4 (at time point 4) and
MEAN yield similar associations. Even though it is
expected that longitudinal measures provide more
information, this was not proven in the study. One
possible explanation is the much-reduced sample size
when using the longitudinal data.
It is intriguing that two top hits (one from fine-mapping)
were identified in the subgroup only. After adding more
samples from Generation 3 (mean age at baseline was
40.1 compared with 33.8 for the subgroup), the associa-
tion in the subgroup at 47.6 Mbp was diluted. It is
noteworthythatthethreedifferentgenerationsintheFHS
may have different environmental exposures. Thus,
unmeasured environmental factors that may interact
with genes might be a major issue in genetic studies.
A limitation of our study is that we only performed
univariate analyses, which may not be able to identify
causative genes or SNPs that are individually weak but
collectively informative. Multivariate approaches will be
helpful in identifying those SNPs. As far as we know,
however, the available machine-learning methods were
developed for random individuals or case-control data,
which restricts their applications to the FHS data, which
contained extended pedigrees.
Conclusion
In summary, there appears to be genetic variation(s) on
chromosome 16 that contribute to BMI. In addition to
age, environmental factors, and major genes with
marginal effects, there may also be different genes that
determine BMI variations at different age periods.
Nevertheless, when we analyzed cross-sectional BMI
data at different time points and the mean for all time
points, we observed consistent associations with BMI at
52.3 Mbp, i.e., the FTO gene. Another region (47.6 Mbp)
may contain genes contributing to BMI by interacting
with environmental factors.
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